

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 6.46299931 |
| 2 | regulation of protein activation cascade (GO:2000257) | 6.31757373 |
| 3 | regulation of complement activation (GO:0030449) | 6.16890316 |
| 4 | exogenous drug catabolic process (GO:0042738) | 5.75026163 |
| 5 | drug catabolic process (GO:0042737) | 5.48916079 |
| 6 | * complement activation, classical pathway (GO:0006958) | 5.48835886 |
| 7 | regulation of fibrinolysis (GO:0051917) | 5.40896320 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 5.37386962 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.29626104 |
| 10 | * complement activation (GO:0006956) | 5.21414513 |
| 11 | ethanol oxidation (GO:0006069) | 5.15213857 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 5.05057995 |
| 13 | * protein activation cascade (GO:0072376) | 4.87429404 |
| 14 | negative regulation of protein activation cascade (GO:2000258) | 4.83717232 |
| 15 | protein carboxylation (GO:0018214) | 4.83460497 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83460497 |
| 17 | fibrinolysis (GO:0042730) | 4.75772426 |
| 18 | negative regulation of complement activation (GO:0045916) | 4.48885721 |
| 19 | regulation of plasminogen activation (GO:0010755) | 4.47168872 |
| 20 | cellular glucuronidation (GO:0052695) | 4.33578900 |
| 21 | urea metabolic process (GO:0019627) | 4.30698145 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15870514 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 4.15870514 |
| 24 | ethanol metabolic process (GO:0006067) | 4.14700264 |
| 25 | glyoxylate metabolic process (GO:0046487) | 4.13387464 |
| 26 | glucuronate metabolic process (GO:0019585) | 4.10023330 |
| 27 | uronic acid metabolic process (GO:0006063) | 4.10023330 |
| 28 | drug metabolic process (GO:0017144) | 4.08208048 |
| 29 | blood coagulation, intrinsic pathway (GO:0007597) | 4.05063606 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98068471 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.98068471 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.96908752 |
| 33 | regulation of apoptotic cell clearance (GO:2000425) | 3.91489850 |
| 34 | negative regulation of blood coagulation (GO:0030195) | 3.82602191 |
| 35 | negative regulation of hemostasis (GO:1900047) | 3.82602191 |
| 36 | regulation of humoral immune response (GO:0002920) | 3.69217311 |
| 37 | bile acid metabolic process (GO:0008206) | 3.68516575 |
| 38 | urea cycle (GO:0000050) | 3.66060000 |
| 39 | opsonization (GO:0008228) | 3.64333988 |
| 40 | negative regulation of coagulation (GO:0050819) | 3.63439373 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.62926995 |
| 42 | acute-phase response (GO:0006953) | 3.56545511 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 3.55905858 |
| 44 | negative regulation of wound healing (GO:0061045) | 3.55151619 |
| 45 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.54703331 |
| 46 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.47517784 |
| 47 | negative regulation of humoral immune response (GO:0002921) | 3.42330229 |
| 48 | daunorubicin metabolic process (GO:0044597) | 3.40792689 |
| 49 | polyketide metabolic process (GO:0030638) | 3.40792689 |
| 50 | doxorubicin metabolic process (GO:0044598) | 3.40792689 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.39324778 |
| 52 | bile acid and bile salt transport (GO:0015721) | 3.38136881 |
| 53 | virion attachment to host cell (GO:0019062) | 3.35995439 |
| 54 | adhesion of symbiont to host cell (GO:0044650) | 3.35995439 |
| 55 | hormone catabolic process (GO:0042447) | 3.35052415 |
| 56 | protein heterotrimerization (GO:0070208) | 3.30855064 |
| 57 | keratan sulfate catabolic process (GO:0042340) | 3.30269105 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27720564 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27720564 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 3.27066462 |
| 61 | negative regulation of sterol transport (GO:0032372) | 3.27066462 |
| 62 | phenylpropanoid metabolic process (GO:0009698) | 3.21737685 |
| 63 | negative regulation of lipase activity (GO:0060192) | 3.14830178 |
| 64 | adhesion of symbiont to host (GO:0044406) | 3.13549085 |
| 65 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.12371641 |
| 66 | positive regulation of blood coagulation (GO:0030194) | 3.09612851 |
| 67 | positive regulation of hemostasis (GO:1900048) | 3.09612851 |
| 68 | primary alcohol catabolic process (GO:0034310) | 3.06813804 |
| 69 | triglyceride homeostasis (GO:0070328) | 3.06468533 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.06468533 |
| 71 | oxidative demethylation (GO:0070989) | 3.05342608 |
| 72 | phospholipid efflux (GO:0033700) | 3.02527234 |
| 73 | positive regulation of extracellular matrix organization (GO:1903055) | 3.00872158 |
| 74 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.98857922 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 2.97257441 |
| 76 | collagen fibril organization (GO:0030199) | 2.93901089 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 2.92118348 |
| 78 | macromolecular complex remodeling (GO:0034367) | 2.92118348 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 2.92118348 |
| 80 | extracellular fibril organization (GO:0043206) | 2.91782799 |
| 81 | positive regulation of coagulation (GO:0050820) | 2.87608370 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 2.83115657 |
| 83 | acute inflammatory response (GO:0002526) | 2.81683853 |
| 84 | primary alcohol metabolic process (GO:0034308) | 2.79093504 |
| 85 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.78127450 |
| 86 | amino-acid betaine metabolic process (GO:0006577) | 2.77747529 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 2.76686819 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76097321 |
| 89 | extracellular matrix assembly (GO:0085029) | 2.76049175 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 2.73652978 |
| 91 | regulation of acute inflammatory response (GO:0002673) | 2.71841222 |
| 92 | type B pancreatic cell proliferation (GO:0044342) | 2.71765583 |
| 93 | fibril organization (GO:0097435) | 2.71503235 |
| 94 | negative regulation of fatty acid transport (GO:2000192) | 2.66167825 |
| 95 | cholesterol efflux (GO:0033344) | 2.65858867 |
| 96 | cell migration involved in heart development (GO:0060973) | 2.64501662 |
| 97 | response to mercury ion (GO:0046689) | 2.62781419 |
| 98 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.61148028 |
| 99 | skin morphogenesis (GO:0043589) | 2.60229803 |
| 100 | regulation of blood coagulation (GO:0030193) | 2.58609359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.48303676 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.48850089 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.69828283 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.34726616 |
| 5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.26841970 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18988900 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.03503396 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.99622633 |
| 9 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.88938237 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.50786158 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.48087197 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30805261 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.25065521 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.16865353 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07821309 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06061198 |
| 17 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.96269259 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82030324 |
| 19 | CJUN_26792858_Chip-Seq_BT549_Human | 1.81780900 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81179975 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63656832 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62615195 |
| 23 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61672716 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59499227 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58904424 |
| 26 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.58064073 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55636717 |
| 28 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53512109 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.52117271 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.47018110 |
| 31 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41352549 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41352549 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38879748 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37859723 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36408753 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33636552 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28712630 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28565096 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26269193 |
| 40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.24033360 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21214656 |
| 42 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19475953 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17144873 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16002207 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12384175 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12247109 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10686246 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10404237 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10404237 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08958757 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07911666 |
| 52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05616153 |
| 53 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04780252 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04437354 |
| 55 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04354957 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02066212 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99829967 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99324926 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98076611 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96458028 |
| 61 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96024954 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95909663 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95875873 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94757105 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94727758 |
| 66 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94691666 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94045263 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93470668 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92673097 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92301105 |
| 71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91565248 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91342650 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91210070 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91129236 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88560716 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86496514 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85513846 |
| 78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85336524 |
| 79 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85175059 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85131942 |
| 81 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84858379 |
| 82 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.84098529 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83770946 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83352420 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82710395 |
| 86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.81153294 |
| 87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.81153294 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80556569 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80556569 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.78320716 |
| 91 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76702491 |
| 92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75380900 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.75141644 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73240603 |
| 95 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.73097959 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71587347 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.71529261 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.71389492 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71268292 |
| 100 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.70877736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.55815601 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.97923581 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.89888290 |
| 4 | MP0005275_abnormal_skin_tensile | 4.71241750 |
| 5 | MP0005360_urolithiasis | 3.57619448 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.29340948 |
| 7 | MP0005365_abnormal_bile_salt | 3.28974255 |
| 8 | MP0001958_emphysema | 2.96840093 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.86814166 |
| 10 | MP0003279_aneurysm | 2.74462105 |
| 11 | MP0004272_abnormal_basement_membrane | 2.72305886 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.58905269 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44605184 |
| 14 | MP0003252_abnormal_bile_duct | 2.26957304 |
| 15 | MP0009840_abnormal_foam_cell | 2.14883321 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.09154422 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.08478078 |
| 18 | MP0006054_spinal_hemorrhage | 2.05401776 |
| 19 | MP0003868_abnormal_feces_composition | 1.96090931 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.94046892 |
| 21 | MP0005023_abnormal_wound_healing | 1.90333884 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.87156154 |
| 23 | MP0003195_calcinosis | 1.83070908 |
| 24 | MP0001542_abnormal_bone_strength | 1.73909037 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.70455148 |
| 26 | MP0002295_abnormal_pulmonary_circulatio | 1.67271445 |
| 27 | MP0002108_abnormal_muscle_morphology | 1.62725112 |
| 28 | MP0005670_abnormal_white_adipose | 1.53639577 |
| 29 | MP0002060_abnormal_skin_morphology | 1.48016221 |
| 30 | MP0005508_abnormal_skeleton_morphology | 1.44991424 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.39436087 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.38945076 |
| 33 | MP0005332_abnormal_amino_acid | 1.32630395 |
| 34 | MP0000751_myopathy | 1.32334180 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.30030536 |
| 36 | MP0005164_abnormal_response_to | 1.24335210 |
| 37 | MP0002933_joint_inflammation | 1.18780935 |
| 38 | MP0000767_abnormal_smooth_muscle | 1.18606057 |
| 39 | MP0000604_amyloidosis | 1.13647855 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.13395960 |
| 41 | MP0001661_extended_life_span | 1.11479591 |
| 42 | MP0002896_abnormal_bone_mineralization | 1.11395584 |
| 43 | MP0001243_abnormal_dermal_layer | 1.08446000 |
| 44 | MP0003091_abnormal_cell_migration | 1.08225199 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.03271000 |
| 46 | MP0002971_abnormal_brown_adipose | 1.01621462 |
| 47 | MP0003724_increased_susceptibility_to | 1.00711343 |
| 48 | MP0005390_skeleton_phenotype | 1.00638930 |
| 49 | MP0005595_abnormal_vascular_smooth | 0.99196590 |
| 50 | MP0002254_reproductive_system_inflammat | 0.99183459 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 0.97693847 |
| 52 | MP0004858_abnormal_nervous_system | 0.96872594 |
| 53 | MP0003011_delayed_dark_adaptation | 0.95855594 |
| 54 | MP0001533_abnormal_skeleton_physiology | 0.93805425 |
| 55 | MP0000609_abnormal_liver_physiology | 0.91050081 |
| 56 | MP0000249_abnormal_blood_vessel | 0.90027493 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 0.88466042 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 0.86581157 |
| 59 | MP0002168_other_aberrant_phenotype | 0.85493897 |
| 60 | MP0005058_abnormal_lysosome_morphology | 0.85086913 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 0.84274511 |
| 62 | MP0003950_abnormal_plasma_membrane | 0.83482774 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.83354021 |
| 64 | MP0002998_abnormal_bone_remodeling | 0.82381612 |
| 65 | MP0004883_abnormal_blood_vessel | 0.81560639 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.81409961 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 0.76609477 |
| 68 | MP0008004_abnormal_stomach_pH | 0.76068132 |
| 69 | MP0009643_abnormal_urine_homeostasis | 0.72476399 |
| 70 | MP0002133_abnormal_respiratory_system | 0.71947476 |
| 71 | MP0005388_respiratory_system_phenotype | 0.71947476 |
| 72 | MP0002128_abnormal_blood_circulation | 0.70287499 |
| 73 | MP0000343_altered_response_to | 0.69919030 |
| 74 | MP0003448_altered_tumor_morphology | 0.69042857 |
| 75 | MP0009053_abnormal_anal_canal | 0.68130215 |
| 76 | MP0002282_abnormal_trachea_morphology | 0.67266048 |
| 77 | MP0000467_abnormal_esophagus_morphology | 0.64286736 |
| 78 | MP0001915_intracranial_hemorrhage | 0.64205791 |
| 79 | MP0000163_abnormal_cartilage_morphology | 0.64096036 |
| 80 | MP0005165_increased_susceptibility_to | 0.64041174 |
| 81 | MP0003186_abnormal_redox_activity | 0.63762864 |
| 82 | MP0003941_abnormal_skin_development | 0.62819615 |
| 83 | MP0005166_decreased_susceptibility_to | 0.61074300 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.59111134 |
| 85 | MP0003329_amyloid_beta_deposits | 0.58224300 |
| 86 | MP0005408_hypopigmentation | 0.57982682 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.57521334 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57207010 |
| 89 | MP0005409_darkened_coat_color | 0.57191625 |
| 90 | MP0001756_abnormal_urination | 0.56218551 |
| 91 | MP0002115_abnormal_skeleton_extremities | 0.55997912 |
| 92 | MP0009763_increased_sensitivity_to | 0.55750420 |
| 93 | MP0000462_abnormal_digestive_system | 0.55333251 |
| 94 | MP0006138_congestive_heart_failure | 0.55314070 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.54951099 |
| 96 | MP0009764_decreased_sensitivity_to | 0.54354112 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.52994667 |
| 98 | MP0001614_abnormal_blood_vessel | 0.52592588 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.51955976 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.51272072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 8.08359312 |
| 2 | * Abnormality of complement system (HP:0005339) | 6.46913242 |
| 3 | Protrusio acetabuli (HP:0003179) | 6.07125456 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.75490631 |
| 5 | * Systemic lupus erythematosus (HP:0002725) | 5.29545254 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.14189479 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.92253308 |
| 8 | Glomerulonephritis (HP:0000099) | 4.71007712 |
| 9 | Aortic aneurysm (HP:0004942) | 4.36376309 |
| 10 | Aortic dissection (HP:0002647) | 4.12000626 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.09137594 |
| 12 | Nephritis (HP:0000123) | 3.98481139 |
| 13 | Vascular tortuosity (HP:0004948) | 3.81448983 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64500602 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.61708254 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.60994217 |
| 17 | Broad metatarsal (HP:0001783) | 3.41347678 |
| 18 | Ankle contracture (HP:0006466) | 3.37846497 |
| 19 | Joint hemorrhage (HP:0005261) | 3.37763022 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.37200762 |
| 21 | Soft skin (HP:0000977) | 3.30957559 |
| 22 | Follicular hyperkeratosis (HP:0007502) | 3.29185038 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.26235976 |
| 24 | Mitral stenosis (HP:0001718) | 3.24479788 |
| 25 | Cervical subluxation (HP:0003308) | 3.20682175 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19840848 |
| 27 | Arterial tortuosity (HP:0005116) | 3.12550471 |
| 28 | Xanthomatosis (HP:0000991) | 3.09212909 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.99802769 |
| 30 | Bladder diverticulum (HP:0000015) | 2.94803078 |
| 31 | Peritonitis (HP:0002586) | 2.89409714 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 2.87372925 |
| 33 | Wormian bones (HP:0002645) | 2.79817615 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79357809 |
| 35 | Atrophic scars (HP:0001075) | 2.70874298 |
| 36 | Blue sclerae (HP:0000592) | 2.65036499 |
| 37 | Dilatation of the ascending aorta (HP:0005111) | 2.64757763 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.60567239 |
| 39 | Wrist flexion contracture (HP:0001239) | 2.55883544 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.54804918 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.54676457 |
| 42 | Osteolytic defects of the hand bones (HP:0009699) | 2.51999329 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51999329 |
| 44 | Fragile skin (HP:0001030) | 2.51796575 |
| 45 | Abnormal delivery (HP:0001787) | 2.51688911 |
| 46 | Neonatal short-limb short stature (HP:0008921) | 2.50734118 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43549344 |
| 48 | Aneurysm (HP:0002617) | 2.43271570 |
| 49 | Spondylolisthesis (HP:0003302) | 2.42121774 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39478311 |
| 51 | Fat malabsorption (HP:0002630) | 2.38769112 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.37438079 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.37438079 |
| 54 | Spinal rigidity (HP:0003306) | 2.32890264 |
| 55 | Spontaneous abortion (HP:0005268) | 2.32698157 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.32151789 |
| 57 | Mitral valve prolapse (HP:0001634) | 2.29670820 |
| 58 | Biconcave vertebral bodies (HP:0004586) | 2.29009530 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28187263 |
| 60 | Slender build (HP:0001533) | 2.24761518 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24472877 |
| 62 | Shallow orbits (HP:0000586) | 2.20990962 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.17460549 |
| 64 | Skin nodule (HP:0200036) | 2.17159986 |
| 65 | Joint stiffness (HP:0001387) | 2.10560326 |
| 66 | Hyperextensible skin (HP:0000974) | 2.09555845 |
| 67 | Gingival bleeding (HP:0000225) | 2.09070451 |
| 68 | Vascular calcification (HP:0004934) | 2.07110331 |
| 69 | Abnormality of dentin (HP:0010299) | 2.03814718 |
| 70 | Striae distensae (HP:0001065) | 2.03452421 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.03386516 |
| 72 | Overgrowth (HP:0001548) | 2.00617129 |
| 73 | Abnormality of the acetabulum (HP:0003170) | 1.99916163 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98771391 |
| 75 | Increased connective tissue (HP:0009025) | 1.96809523 |
| 76 | Purpura (HP:0000979) | 1.96378962 |
| 77 | Emphysema (HP:0002097) | 1.95859244 |
| 78 | Mucopolysacchariduria (HP:0008155) | 1.94390387 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94390387 |
| 80 | Aortic regurgitation (HP:0001659) | 1.93986502 |
| 81 | Joint laxity (HP:0001388) | 1.91283808 |
| 82 | Steatorrhea (HP:0002570) | 1.90532118 |
| 83 | Nonimmune hydrops fetalis (HP:0001790) | 1.87582440 |
| 84 | Genu recurvatum (HP:0002816) | 1.86729993 |
| 85 | Wide anterior fontanel (HP:0000260) | 1.86623584 |
| 86 | Ovoid vertebral bodies (HP:0003300) | 1.85432703 |
| 87 | Aortic valve stenosis (HP:0001650) | 1.85060756 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84569780 |
| 89 | Ectopia lentis (HP:0001083) | 1.83498917 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80865111 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80865111 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80865111 |
| 93 | Polycythemia (HP:0001901) | 1.80746707 |
| 94 | Myocardial infarction (HP:0001658) | 1.77612841 |
| 95 | Coxa vara (HP:0002812) | 1.75985853 |
| 96 | Persistence of primary teeth (HP:0006335) | 1.74200790 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.71926207 |
| 98 | Pulmonary artery stenosis (HP:0004415) | 1.69637819 |
| 99 | Amyloidosis (HP:0011034) | 1.69541998 |
| 100 | Gingival overgrowth (HP:0000212) | 1.68913648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.71636701 |
| 2 | MYLK | 4.34036071 |
| 3 | PDGFRA | 3.65116440 |
| 4 | RIPK1 | 3.37851336 |
| 5 | DDR2 | 3.35294085 |
| 6 | FGFR4 | 2.62715011 |
| 7 | TGFBR2 | 2.59671887 |
| 8 | EPHA3 | 2.44047262 |
| 9 | TYK2 | 2.06229721 |
| 10 | MST1R | 2.01554511 |
| 11 | KIT | 1.95193522 |
| 12 | NEK9 | 1.89509564 |
| 13 | CDC42BPA | 1.84844830 |
| 14 | TRIB3 | 1.83467388 |
| 15 | EPHB1 | 1.82567723 |
| 16 | EPHB2 | 1.82093342 |
| 17 | JAK1 | 1.79199699 |
| 18 | SIK1 | 1.61500803 |
| 19 | PIK3CG | 1.55353432 |
| 20 | PDGFRB | 1.52995449 |
| 21 | MET | 1.50461786 |
| 22 | NTRK1 | 1.48502888 |
| 23 | LATS1 | 1.46292375 |
| 24 | LATS2 | 1.43788534 |
| 25 | ABL2 | 1.42858329 |
| 26 | FGFR3 | 1.40094661 |
| 27 | PAK2 | 1.32392547 |
| 28 | PTK2 | 1.31936705 |
| 29 | GRK1 | 1.31378722 |
| 30 | TTN | 1.30441590 |
| 31 | NLK | 1.28951114 |
| 32 | TESK1 | 1.28942099 |
| 33 | AKT3 | 1.27834319 |
| 34 | MAP3K6 | 1.26572998 |
| 35 | GRK5 | 1.21632834 |
| 36 | FER | 1.18758238 |
| 37 | MAPK7 | 1.15864982 |
| 38 | PRPF4B | 1.14909837 |
| 39 | MAP3K3 | 1.13622134 |
| 40 | PIK3CA | 1.01158345 |
| 41 | STK38 | 0.99092242 |
| 42 | PRKD2 | 0.94179494 |
| 43 | TRPM7 | 0.90184106 |
| 44 | LMTK2 | 0.88332310 |
| 45 | PAK4 | 0.87891933 |
| 46 | ADRBK1 | 0.86558969 |
| 47 | MAPKAPK3 | 0.86394494 |
| 48 | TBK1 | 0.85586442 |
| 49 | TIE1 | 0.80773917 |
| 50 | PRKG2 | 0.79408561 |
| 51 | JAK3 | 0.78154399 |
| 52 | ZAP70 | 0.76974461 |
| 53 | MAP3K7 | 0.76807526 |
| 54 | MAP3K2 | 0.75227469 |
| 55 | PRKAA2 | 0.73640990 |
| 56 | DMPK | 0.69366620 |
| 57 | GSK3A | 0.64938523 |
| 58 | PRKD1 | 0.63421110 |
| 59 | PDPK1 | 0.62737264 |
| 60 | STK38L | 0.60538525 |
| 61 | ADRBK2 | 0.60090552 |
| 62 | RET | 0.59319521 |
| 63 | MAPK4 | 0.59090454 |
| 64 | MAP3K12 | 0.57231981 |
| 65 | MAP3K1 | 0.56733696 |
| 66 | ROCK1 | 0.56683581 |
| 67 | MTOR | 0.55225270 |
| 68 | PKN2 | 0.54786904 |
| 69 | MAPK11 | 0.54765358 |
| 70 | PRKACG | 0.54199065 |
| 71 | HIPK2 | 0.52507125 |
| 72 | CAMK2G | 0.50592508 |
| 73 | GRK6 | 0.50452127 |
| 74 | FLT3 | 0.50096745 |
| 75 | ERBB4 | 0.49983665 |
| 76 | RPS6KA2 | 0.49587499 |
| 77 | IGF1R | 0.49327092 |
| 78 | JAK2 | 0.47332238 |
| 79 | GRK7 | 0.45583239 |
| 80 | MAP2K1 | 0.45392151 |
| 81 | SRC | 0.43852166 |
| 82 | LIMK1 | 0.42714554 |
| 83 | MAPK12 | 0.42686733 |
| 84 | DAPK3 | 0.40865102 |
| 85 | ROCK2 | 0.39675275 |
| 86 | STK3 | 0.39636195 |
| 87 | KSR2 | 0.38842510 |
| 88 | MARK2 | 0.36612225 |
| 89 | TGFBR1 | 0.36106513 |
| 90 | ILK | 0.35421918 |
| 91 | PTK6 | 0.34860319 |
| 92 | IRAK1 | 0.34711531 |
| 93 | PRKCE | 0.34515865 |
| 94 | BMX | 0.33019218 |
| 95 | ERBB2 | 0.32361108 |
| 96 | ABL1 | 0.31239092 |
| 97 | MAP3K13 | 0.31144651 |
| 98 | BLK | 0.31121769 |
| 99 | PRKG1 | 0.30990463 |
| 100 | MELK | 0.30925197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.32460204 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.47739414 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31631961 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.19876408 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14189147 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.12634064 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71563373 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.70551128 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.65830712 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.42337071 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39827752 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.29217644 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29027677 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.20773284 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20334333 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15188510 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.10661907 |
| 18 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03026961 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.97509737 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72728189 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.71677583 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71566146 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66020858 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53893289 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49821542 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.48223194 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.43876530 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37101531 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.37083332 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25091690 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21951225 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20950916 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19295803 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05626256 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02200580 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00708165 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.97754014 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94360249 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94030020 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90677704 |
| 41 | * Pertussis_Homo sapiens_hsa05133 | 0.89888392 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87927750 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85576104 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.84470884 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.82711023 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78228989 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76452588 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76133711 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.75331756 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73180166 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.64693048 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63133791 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58370481 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58027529 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56272110 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55195628 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53396330 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50468290 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.47470241 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45396217 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42409873 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.42172992 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41734707 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40251075 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39743539 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36234638 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35436421 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35426733 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35015129 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33951817 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33865413 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32559771 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30699373 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30528800 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.28616935 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.27635512 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27225321 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26241543 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26215938 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24009920 |
| 81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.22982507 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22783661 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20414311 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.15210408 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14418261 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.13342966 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13192281 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12707971 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12133026 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11594100 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.11045991 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.10793721 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.10054788 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08894644 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07337547 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.07241425 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07117356 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07098322 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.06903885 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03907265 |

